看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040984 Size: 64 KB 网页链接
$Agile Therapeutics(AGRX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001037389-19-000003 Size: 13 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-02-11 AccNo: 0001104659-19-007141 Size: 78 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-23 AccNo: 0001047469-19-000195 Size: 351 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-23 AccNo: 0001104659-19-002849 Size: 282 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-10 AccNo: 0001104659-19-001481 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001104659-19-000994 Size: 2 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-03 AccNo: 0001104659-19-000502 Size: 23 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Agile Therapeutics, Inc.(AGRX)$ 8-K - Current report Filed: 2018-12-13 AccNo: 0001104659-18-072839 Size: 43 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics, Inc.(AGRX)$ EFFECT - Notice of Effectiveness Filed: 2018-11-14 AccNo: 9999999995-18-002891 Size: 1 KB 网页链接